After unlikely move to UNC Charlotte, scientist makes cancer breakthrough
Cancer researcher Pinku Mukherjee made a cancer discovery at UNC Charlotte in 2009 and has since started a biotech company, OncoTab, Inc. that is now headed by her husband, Rahul Puri. They are making a blood test that can help diagnose breast and pancreatic cancers.
Cancer researcher receives UNC Board of Governors top faculty honor
Distinguished cancer researcher Pinku Mukherjee was honored with the O. Max Gardner Award – the highest faculty accolade given by the Board of Governors of the University of North Carolina. She was presented the honor formally Friday, April 10.
CanDiag Raises $500K for Breast-Cancer Diagnostics
CanDiag Inc., a clinical research start-up focused on developing diagnostics for early-stage breast cancer detection, said it has raised funding of more than $500,000 from an angel syndicate.
CanDiag Inc., Blood test for detecting early-stage breast cancer
CanDiag Inc. spun out of the University of North Carolina at Charlotte to develop an antibody-based blood test for detecting early-stage breast cancer. The start-up will first use the technology to develop a blood test for breast cancer recurrence, but the ultimate goal is to develop a test that can be used for women who have an abnormal mammogram; the test would be performed in lieu of additional expensive imaging studies and before performing biopsies.
UNC spin-off CanDiag Inc. named grand-prize winner in Charlotte Venture Challenge
A UNC Charlotte spin-off that developed a more accurate test to detect breast cancer was named the grand-prize winner of the Charlotte Venture Challenge on Thursday.
OncoTAb Blood Test Enables Earlier Detection of Breast Cancer in Women with Dense Breast Tissue
OncoTAb, Inc., a University of North Carolina at Charlotte (UNCC) spin-out company, released the findings from a clinical study testing its Agkura™ Personalized Score, a non-invasive blood test for the early detection of breast cancer in women with dense breast tissue.
OncoTAb to Highlight a Tumor Specific Marker to Enable Earlier Detection of Breast Cancer in Women with Dense Breasts at 2015 SABCS
OncoTAb, Inc., a University of North Carolina at Charlotte (UNCC) spin-out company, announced it will present scientific data highlighting a non-invasive blood test to aid in the early detection of breast cancer in women with dense breast tissue.
OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award
OncoTAb, Inc., a University of North Carolina at Charlotte (UNC Charlotte) spin-out company, announced that Pinku Mukherjee, Ph.D. has received the O. Max Gardner Award, the UNC Board of Governors’ highest faculty honor. Mukherjee received the award, which recognizes faculty contributions to humanity’s welfare, for her innovative research and development of cancer diagnostics and treatments.
OncoTab, Inc. to Present at Biotech Showcase
OncoTab, Inc., a University of North Carolina at Charlotte (UNC Charlotte) spin-out company, announced today that it has been selected to present at the 7th Annual Biotech Showcase™. The invitation to participate in the prestigious biotechnology showcase comes on the heels of OncoTab’s rebranding and technology platform expansion.
CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc.
CanDiag, Inc., a University of North Carolina at Charlotte (UNC Charlotte) spin-out company has changed its name to OncoTab, Inc. “The new name is a more accurate representation of where we are today,” said CEO and Chief Science Officer, Dr. Pinku Mukherjee, PhD.
CanDiag Inc., a University of North Carolina at Charlotte Spin-out Raises Angel Capital
CanDiag, Inc., a University of North Carolina at Charlotte (UNC Charlotte) spin-out company focused on early-stage breast cancer detection has successfully closed on over $500,000 in a syndicated angel capital financing.
CanDiag’s Early Breast Cancer Detection Focus Garners a $50,000 Win at Charlotte Venture Challenge
CanDiag, Inc., a spin-off of the University of North Carolina (UNC) at Charlotte focused on early-stage breast cancer detection, has been named the grand prize winner of the 2012 Charlotte Venture Challenge.